NASDAQ:LFMD LifeMD (LFMD) Stock Forecast, Price & News $2.18 +0.01 (+0.46%) (As of 05/26/2023 03:59 PM ET) Add Compare Share Share Today's Range$2.06▼$2.2050-Day Range$1.15▼$2.1852-Week Range$1.14▼$3.22Volume84,400 shsAverage Volume96,886 shsMarket Capitalization$70.65 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media LifeMD MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside221.1% Upside$7.00 Price TargetShort InterestBearish7.73% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.10Based on 6 Articles This WeekInsider TradingAcquiring Shares$59,678 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.88 out of 5 starsMedical Sector741st out of 1,010 stocksOffices & Clinics Of Medical Doctors Industry5th out of 7 stocks 3.5 Analyst's Opinion Consensus RatingLifeMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $7.00, LifeMD has a forecasted upside of 221.1% from its current price of $2.18.Amount of Analyst CoverageLifeMD has only been the subject of 1 research reports in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted7.73% of the float of LifeMD has been sold short.Short Interest Ratio / Days to CoverLifeMD has a short interest ratio ("days to cover") of 19.4, which indicates bearish sentiment.Change versus previous monthShort interest in LifeMD has recently increased by 0.51%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldLifeMD does not currently pay a dividend.Dividend GrowthLifeMD does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LFMD. Previous Next 3.9 News and Social Media Coverage News SentimentLifeMD has a news sentiment score of 1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for LifeMD this week, compared to 1 article on an average week.Search Interest6 people have searched for LFMD on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows2 people have added LifeMD to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LifeMD insiders have bought more of their company's stock than they have sold. Specifically, they have bought $59,678.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders18.89% of the stock of LifeMD is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 17.01% of the stock of LifeMD is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeMD is -1.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeMD is -1.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About LifeMD (NASDAQ:LFMD) StockLifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded in 1987 and is headquartered in New York, NY.Read More Receive LFMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter. Email Address LFMD Stock News HeadlinesMay 27, 2023 | americanbankingnews.comInsider Buying: LifeMD, Inc. (NASDAQ:LFMD) CEO Acquires 17,664 Shares of StockMay 25, 2023 | americanbankingnews.comStefan Galluppi Buys 10,000 Shares of LifeMD, Inc. (NASDAQ:LFMD) StockMay 29, 2023 | Legacy Research (Affiliate) (Ad)Sell every Stock except ONE Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...May 23, 2023 | finance.yahoo.comLifeMD, Inc. to Present at the June 1st Virtual Investor SummitMay 12, 2023 | marketwatch.comLifeMD, Inc. Reports First Quarter 2023 Results; Record Revenues and Adjusted EBITDAMay 11, 2023 | markets.businessinsider.comLifeMD earnings: here's what Wall Street expectsMay 10, 2023 | americanbankingnews.comLifeMD (LFMD) Set to Announce Quarterly Earnings on FridayMay 3, 2023 | finance.yahoo.comLifeMD, Inc. to Announce First Quarter 2023 Financial Results on May 12, 2023May 29, 2023 | Legacy Research (Affiliate) (Ad)Sell every Stock except ONE Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...April 24, 2023 | finance.yahoo.comLifeMD Launches New Features and Membership Plans to Improve Patient Experience and Broaden Access to HealthcareMarch 26, 2023 | americanbankingnews.comBTIG Research Trims LifeMD (NASDAQ:LFMD) Target Price to $7.00March 22, 2023 | finance.yahoo.comLifeMD, Inc. Announces Closing of New $40 Million Credit FacilityMarch 21, 2023 | americanbankingnews.comLifeMD (LFMD) Set to Announce Earnings on WednesdayMarch 7, 2023 | finance.yahoo.comLifeMD, Inc. to Announce Fourth Quarter, Full Year 2022 Financial Results on March 22, 2023February 10, 2023 | finance.yahoo.comLifeMD Appoints Dr. Joan LaRovere to its Board of DirectorsJanuary 4, 2023 | finance.yahoo.comLifeMD Appoints Jessica Friedeman as Chief Marketing Officer to Support the Company’s Rapid Expansion into Virtual Primary CareNovember 22, 2022 | finance.yahoo.comLifeMD, Inc. Ranked Number 140 Fastest Growing Company on Deloitte’s 2022 North America Technology Fast 500™November 18, 2022 | finance.yahoo.comLifeMD, Inc. to Participate in Upcoming Investor ConferencesNovember 15, 2022 | markets.businessinsider.comBTIG Keeps Their Buy Rating on LifeMD (LFMD)November 10, 2022 | finance.yahoo.comLifeMD, Inc. Reports Third Quarter 2022 ResultsOctober 26, 2022 | finance.yahoo.comLifeMD, Inc. to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 10, 2022September 20, 2022 | marketscreener.comLIFEMD, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.comSeptember 20, 2022 | marketscreener.comLifeMD : Statement of Changes in Beneficial Ownership - Form 4 - Marketscreener.comSeptember 20, 2022 | globenewswire.comLifeMD Appoints Bobby Jindal to the Board of Directors - GlobeNewswireSeptember 20, 2022 | finance.yahoo.comLifeMD Appoints Bobby Jindal to the Board of DirectorsSeptember 15, 2022 | marketscreener.comLIFEMD, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K) - Marketscreener.comSeptember 14, 2022 | finance.yahoo.comLifeMD Expands Primary Care Platform’s Diagnostic Capabilities with New At-Home Screening Kits For Early Warning Signs Of Cancer - Yahoo FinanceSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive LFMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter. Email Address LFMD Company Calendar Last Earnings3/22/2023Today5/29/2023Next Earnings (Estimated)8/10/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Offices & clinics of medical doctors Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:LFMD CUSIPN/A CIK948320 Webwww.lifemd.com Phone(866) 351-5907FaxN/AEmployees196Year FoundedN/APrice Target and Rating Average Stock Price Forecast$7.00 High Stock Price Forecast$7.00 Low Stock Price Forecast$7.00 Forecasted Upside/Downside+221.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-45,540,000.00 Net Margins-29.44% Pretax Margin-28.29% Return on Equity-7,255.81% Return on Assets-67.31% Debt Debt-to-Equity RatioN/A Current Ratio0.71 Quick Ratio0.58 Sales & Book Value Annual Sales$119.03 million Price / Sales0.59 Cash FlowN/A Price / Cash FlowN/A Book Value($0.38) per share Price / Book-5.74Miscellaneous Outstanding Shares32,410,000Free Float26,289,000Market Cap$70.65 million OptionableOptionable Beta1.30 Key ExecutivesJustin SchreiberChairman & Chief Executive OfficerAlexander MironovPresidentBrad RobertsChief Operating OfficerMarc David BenathenChief Financial OfficerStefan GalluppiDirector & Chief Innovation OfficerKey CompetitorsConcord Medical ServicesNYSE:CCMOncology InstituteNASDAQ:TOISHL TelemedicineNASDAQ:SHLTGalectoNASDAQ:GLTOPraxis Precision MedicinesNASDAQ:PRAXView All CompetitorsInsiders & InstitutionsRoyce & Associates LPBought 91,306 shares on 5/23/2023Ownership: 3.302%Stefan GalluppiBought 10,000 shares on 5/23/2023Total: $21,700.00 ($2.17/share)Justin SchreiberBought 17,664 shares on 5/22/2023Total: $37,977.60 ($2.15/share)JPMorgan Chase & Co.Bought 88,792 shares on 5/18/2023Ownership: 0.274%Jane Street Group LLCSold 32,017 shares on 5/16/2023Ownership: 0.128%View All Insider TransactionsView All Institutional Transactions LFMD Stock - Frequently Asked Questions Should I buy or sell LifeMD stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifeMD in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" LFMD shares. View LFMD analyst ratings or view top-rated stocks. What is LifeMD's stock price forecast for 2023? 1 Wall Street analysts have issued 1-year price targets for LifeMD's shares. Their LFMD share price forecasts range from $7.00 to $7.00. On average, they expect the company's share price to reach $7.00 in the next year. This suggests a possible upside of 221.1% from the stock's current price. View analysts price targets for LFMD or view top-rated stocks among Wall Street analysts. How have LFMD shares performed in 2023? LifeMD's stock was trading at $1.94 at the start of the year. Since then, LFMD stock has increased by 12.4% and is now trading at $2.18. View the best growth stocks for 2023 here. When is LifeMD's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023. View our LFMD earnings forecast. How were LifeMD's earnings last quarter? LifeMD, Inc. (NASDAQ:LFMD) posted its quarterly earnings results on Wednesday, March, 22nd. The company reported ($0.40) EPS for the quarter. The business earned $28.12 million during the quarter. LifeMD had a negative trailing twelve-month return on equity of 7,255.81% and a negative net margin of 29.44%. What guidance has LifeMD issued on next quarter's earnings? LifeMD updated its second quarter 2023 earnings guidance on Friday, May, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $35.00 million-$36.00 million, compared to the consensus revenue estimate of $35.70 million. What is LifeMD's stock symbol? LifeMD trades on the NASDAQ under the ticker symbol "LFMD." Who are LifeMD's major shareholders? LifeMD's stock is owned by a number of retail and institutional investors. Top institutional investors include Royce & Associates LP (3.36%), Royce & Associates LP (3.30%), B. Riley Financial Inc. (2.84%), BlackRock Inc. (1.17%), HighTower Advisors LLC (0.36%) and JPMorgan Chase & Co. (0.27%). Insiders that own company stock include Bertrand Velge, Brad Michael Roberts, Corey Deutsch, Eric Harold Yecies, Happy David Walters, Joseph Ditrolio, Justin Schreiber, Marc David Benathen, Naveen Bhatia and Stefan Galluppi. View institutional ownership trends. How do I buy shares of LifeMD? Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is LifeMD's stock price today? One share of LFMD stock can currently be purchased for approximately $2.18. How much money does LifeMD make? LifeMD (NASDAQ:LFMD) has a market capitalization of $70.65 million and generates $119.03 million in revenue each year. The company earns $-45,540,000.00 in net income (profit) each year or ($1.26) on an earnings per share basis. How many employees does LifeMD have? The company employs 196 workers across the globe. How can I contact LifeMD? LifeMD's mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The official website for the company is www.lifemd.com. The company can be reached via phone at (866) 351-5907 or via email at cdeutsch@lifemd.com. This page (NASDAQ:LFMD) was last updated on 5/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.